Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
: Low alkaline phosphatase (ALP), typically under 40 IU/L in adults, is far less common than elevated levels and often points to specific nutritional deficiencies, genetic conditions, or metabolic disorders that standard blood panels may overlook. Common causes include zinc or magnesium deficiency (both essential cofactors for ALP enzyme function), malnutrition or severe protein deficiency, hypothyroidism, pernicious anemia and vitamin B12 deficiency, celiac disease, and Wilson disease (copper accumulation). Certain medications also suppress ALP, including oral contraceptives, hormone replacement therapy, bisphosphonates like alendronate used for osteoporosis, corticosteroids, and clofibrate. A rare but serious genetic cause is hypophosphatasia (HPP), an inherited disorder of the ALPL gene that impairs bone mineralization, causing rickets in children, recurrent fractures, premature tooth loss, muscle weakness, and chronic bone pain; persistently low ALP is the biochemical hallmark, and diagnosis is often delayed for years. Additional considerations include recent cardiac surgery or massive blood transfusion, achondroplasia, cretinism, milk-alkali syndrome, and post-menopausal estrogen therapy. Because ALP requires zinc and magnesium to function, correcting these deficiencies frequently restores normal levels. Evaluation should include repeat ALP testing to confirm the finding, serum zinc and magnesium, vitamin B12, thyroid function, celiac serology, and copper/ceruloplasmin if Wilson disease is suspected. In suspected HPP, elevated vitamin B6 and urinary phosphoethanolamine support the diagnosis, with ALPL gene sequencing for confirmation. Treatment targets the underlying cause: nutritional repletion, thyroid hormone replacement, medication adjustment, or enzyme replacement therapy (asfotase alfa) for HPP. Because low ALP can signal treatable deficiencies or an undiagnosed genetic bone disorder, it should not be dismissed as an incidental finding.
Alkaline phosphatase (Alk Phos) is an enzyme found in many tissues, especially the liver, bones and digestive tract. While elevated Alk Phos often raises concern for liver or bone disease, abnormally low levels can also signal underlying issues. Understanding the reasons for low alkaline phosphatase helps you and your doctor identify hidden conditions and take appropriate steps.
Alk Phos helps break down proteins and plays a role in bone formation and liver function. A standard adult reference range is roughly 44–147 IU/L, though labs vary. Values below this range are less common but meaningful.
Low Alk Phos can stem from nutritional, genetic, endocrine or systemic causes. Key factors include:
Nutrient deficiencies
• Zinc: a cofactor for Alk Phos production
• Magnesium: essential for enzyme activity
• Vitamin B6 (pyridoxine): involved in enzyme synthesis
Genetic disorders
• Hypophosphatasia: rare inherited condition causing low Alk Phos, defective bone mineralization and dental problems
Endocrine and metabolic conditions
• Hypothyroidism: underactive thyroid can suppress enzyme levels
• Pernicious anemia or other anemias: low red blood cell counts may correlate with reduced Alk Phos
• Celiac disease: intestinal damage impairs nutrient absorption, including zinc and magnesium
Medication effects
Certain drugs can lower Alk Phos, though this is rare. Examples include high-dose estrogens and some cancer therapies.
When routine labs show low Alk Phos, look deeper for these less obvious conditions:
Hypophosphatasia
– Genetic mutation in the ALPL gene leads to defective bone mineralization.
– Symptoms vary: from severe infantile forms to mild adult-onset with stress fractures or dental issues.
– Diagnosis: persistently low Alk Phos, elevated serum pyridoxal 5′-phosphate (vitamin B6) and genetic testing.
Subclinical Hypothyroidism
– Mild thyroid underactivity may not cause obvious symptoms but can depress Alk Phos.
– Check thyroid-stimulating hormone (TSH) and free T4 levels.
Malabsorption Syndromes
– Conditions like celiac disease damage the gut lining, reducing absorption of zinc, magnesium and vitamin B6.
– Look for gastrointestinal symptoms (bloating, diarrhea) or associated anemia.
Nutritional Deficits
– Inadequate dietary intake, especially in strict vegetarians or people with restrictive diets, can lead to low micronutrient levels.
– Assess dietary history and consider a brief nutrition evaluation.
Hematologic Disorders
– Pernicious anemia (vitamin B12 deficiency) and other anemias sometimes correlate with lower Alk Phos activity.
– Evaluate complete blood count (CBC), vitamin B12 and folate.
If your blood work shows low Alk Phos, follow a structured approach:
Confirm the Result
Review Medications and Supplements
Assess Nutritional Status
Screen for Thyroid Dysfunction
Investigate Malabsorption
Evaluate Bone Health
Genetic Counseling
Monitor Over Time
Low Alk Phos itself is not a disease but a clue. Discuss your results with a healthcare professional, especially if you have:
For a free, online symptom check, using the doctor approved Ubie Symptom Checker, visit:
https://ubiehealth.com/
This tool can help you gather insights before your appointment.
While underlying conditions require targeted treatment, you can take these general steps:
Low alkaline phosphatase levels often reflect a hidden metabolism, nutrition or genetic issue. By following the evaluation steps and working closely with your healthcare team, you can uncover the root cause and begin appropriate treatment. Always discuss any serious or worrying symptoms with a medical professional. If you experience signs that could be life threatening—such as severe abdominal pain, neurological changes or unexplained bleeding—speak to a doctor immediately.
(References)
* Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. Epub 2016 Feb 19. PMID: 26893260.
* Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. Epub 2017 Jul 25. PMID: 28888853.
* Del Angel G, Reynders J, Negron C, Steinbrecher T, Mornet E. Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia. Hum Mutat. 2020 Jul;41(7):1250-1262. doi: 10.1002/humu.24010. Epub 2020 Mar 18. PMID: 32160374; PMCID: PMC7317754.
* Vimalraj S. Alkaline phosphatase: Structure, expression and its function in bone mineralization. Gene. 2020 Sep 5;754:144855. doi: 10.1016/j.gene.2020.144855. Epub 2020 Jun 6. PMID: 32522695.
* Mornet E, Taillandier A, Domingues C, Dufour A, Benaloun E, Lavaud N, Wallon F, Rousseau N, Charle C, Guberto M, Muti C, Simon-Bouy B. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet. 2021 Feb;29(2):289-299. doi: 10.1038/s41431-020-00732-6. Epub 2020 Sep 24. PMID: 32973344; PMCID: PMC7868366.
* Fenn JS, Lorde N, Ward JM, Borovickova I. Hypophosphatasia. J Clin Pathol. 2021 Oct;74(10):635-640. doi: 10.1136/jclinpath-2021-207426. Epub 2021 Apr 30. PMID: 33931563.
* Riancho JA. Diagnostic Approach to Patients with Low Serum Alkaline Phosphatase. Calcif Tissue Int. 2023 Mar;112(3):289-296. doi: 10.1007/s00223-022-01039-y. Epub 2022 Nov 8. PMID: 36348061.
* Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626. PMID: 37249457; PMCID: PMC10665056.
* Khan AA, Brandi ML, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Lewiecki EM. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int. 2024 Mar;35(3):431-438. doi: 10.1007/s00198-023-06844-1. Epub 2023 Nov 20. PMID: 37982857; PMCID: PMC10866785.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.